Much of the interest in a hemopoietic factor in the liver other than vitamin B12 developed in
large measure from the work of Lucy Wills (Wills 1932 , Wills et al. 1937 . She showed in a series of papers that macrocytic aneemia occurring among Hindu women in Bombay responded to injections of 'crude' but not 'refined' liver extract. As Girdwood (1960) and others have indicated, the unknown 'Wills factor' was undoubtedly folate, and folate deficiency and megaloblastic anemia have been extensively studied in Britain. With no lack of appreciation for the many other British workers who provided inspiration for some of our studies, I would mention Ungley (1950 Ungley ( , 1957 , Witts (1961) , Girdwood (1960) and Mollin (1960) as foci of a great many studies which have stimulated our imagination. We have reviewed many of these studies elsewhere (Herbert 1959) , and shall here deal mainly with our own studies in this field.
Development of Serum Folate Assay with Lactobacillus casei
The problem of assessing folate deficiency in man was investigated in 1958 and 1959 with Herman Baker who had just given up an assay for folic acid in blood because Bacillus coagulans, the organism used, had mutated to a point where it was no longer folate dependent (Baker et al. 1959) . The serum folate level as measured by L. casei, the organism used by Usdin et al. (1956) to study whole blood folates, proved to be a sensitive index of folate status in man , Baker et al. 1959 Weinfeld 1962 , Izak et al. 1961 , Davis & Kelly 1962 , Arakawa et al. 1963 , Lindenbaum & Klipstein 1963 , Metz 1963 , Cooke et al. 1963 .
For the past several years we have been using the 'aseptic addition method' (Herbert 1961b , Herbert & Zalusky 1962a ) in which flasks containing 5 ml of double-strength medium, 4 ml of de-ionized water and 1 ml of pH 6'1 phosphate buffer to which 10 mg ascorbic acid was freshly added are autoclaved. To one flask is added 0-1 ml serum; to another 0-2 ml serum; strict asepsis is unnecessary in collecting or transferring the serum. A drop of L. casei is then added to each flask and incubation begun.
This method has the advantages of: (1) Halving the manipulations involved in the assay by deleting the step involving autoclaving of serum in buffer. (2) Allowing use of 1 ml of 1 g % ascorbate, which better preserves serum folates (not more than 350 mg% can be used before autoclaving in the 'standard method', described in 1959 by Baker et al. which most other workers now use, because greater amounts prevent precipitation of protein when serum is autoclaved).
(3) Requiring only 0 3 ml serum (0-1 ml for one sample; 0 2 ml for its duplicate), an especially valuable point when children are studied.
The validity of the assay is unaffected by various minor changes in assay method or medium, as long as contamination of glassware and ingredients by folate is excluded (the commercial grade ingredients, especially casein and glucose, from many drug firms are contaminated with sufficient folate to invalidate the assay). The medium we use (Baker et al. 1959 ) is almost identical to that of Jukes (1955) , but contains twice as much para-aminobenzoic acid. Waters & Mollin (1961) got results essentially identical with ours by reproducing our assay medium except that they used enzymatically hydrolysed casein instead of acid hydrolysed casein and tryptophan, a variation which Usdin et al. (1956) had considered less desirable for a 'dry mix' but equally good for a freshly prepared medium.
Our assay medium is commercially available as a 'dry mix' (just add water and stir) from Baltimore Biological Laboratories (Baltimore, Maryland, USA) and a very similar one from Difco Laboratories (Detroit, Michigan, USA). These 'dry mixes' should be refrigerated to avoid decomposition. They give identical results in our hands.
We routinely collect serum from fasting subjects, because we found that ingestion of chicken or beef liver produced sharp rises in serum L. casei (but not Str. faecalis) folate levels. For example, after a breakfast of chicken livers, one normal subject with a baseline L. casei folate level of 10 ng/ml within 0 5 h reached 20 ng/ml and climbed in another 0 5 h to values of 50-80 ng/ml sustained for four hours. No other food yet studied has shown this striking effect which indicates absorbability of liver folate so great as to be approached only by folic acid itself. It was the striking effect of liver folate which caused us to introduce it into Fig 6 (Herbert & Zalusky 1962a) .
It should be noted here that the abscissa of Fig 1 of our paper on assay and nature of serum folate activity (Herbert & Zalusky 1961b) should have read 'Folic acid (m , g/ml)/100' since the actual folic acid concentration is 1/100 of the abscissa figure, as was made clear in Table I of the same paper. The unfortunate deletion of '/100' led several workers (Waters & Mollin 1961) to believe that we studied the effect of ascorbate on L. casei growth using larger concentrations of folic acid than are used in the assay, and more ascorbic acid, whereas in fact we used the same concentration of folic acid and autoclaved ascorbate-phosphate buffer as in the serum assays.
Again, it is emphasized that variations in methodology are generally unimportant. The important factors are: (1) Cleanliness to avoid contamination with folate (contamination with micro-organisms is rarely a problem because L. casei grows so fast and makes so much lactic acid).
(2) Refrigeration of media to avoid deterioration.
(3) Preservation of serum against oxidative destruction, which we will now take up in more detail.
Lability ofSerum L. casei Folate Ascorbate or other reducing agents such as 2mercaptoethanol preserve the L. casei folate activity in the serum which, unlike the small amount of stable Str. fecalis activity, is highly labile and needs protection against oxidative destruction (Herbert 1960 (Herbert , 1961b . The lability of serum L. casei folate and its protection by ascorbate has been confirmed by others. Waters & Mollin (1961) initially recommended use of less ascorbate (100 mg%) to protect serum folate than the 150 mg % we found desirable in the 'standard method' (Herbert 1960 (Herbert , 1961b . More recently, they have confirmed the advisability of increasing the concentration of ascorbate above 100 mg% (Waters & Mollin 1963) .
In our experience the addition of ascorbate to serum before freezing (Waters & Mollin 1961) at -200 C is unnecessary if the samples will be assayed within two years (Herbert 1962b , Davis & Kelly 1962 . However, if storage before assay will exceed two years, addition of a reducing agent is desirable. Incidentally, the addition of ascorbate partially destroys vitamin B12 (Hutchins et al. 1956 ), and too much ascorbate destroys folate (Scheindlin & Griffith 1951) . (Herbert et al. 1962) .
Concurrently with the studies of Larrabee et al. (1961, 1963) , which defined the intermediate as being 5-CH3-folate-H4, serum folate was concentrated on and eluted from charcoal, and shown by chromatography in four separate solvent systems to be 5-CH3-folate-H4 (or 5-CH3folate-H2, which migrates identically) (Herbert et al. 1962 ) and not to be 5-CH3-folate-triglutamate-H4 which was synthesized to help rule out the possibility (Herbert 1961b ) that the main serum folate might be a triglutamate. In this connexion, it is still possible that the main folates in man may be conjugated since we have not ruled out the possible action on serum folate of natural conjugases in serum before chromatography (Noronha & Aboobaker 1963) .
Production ofPure Nutritional Folate Deficiency in Man
With the possible exception of one study in which baseline folate stores were not determined (Knowles et al. 1961 , Fleming et al. 1963 , pure nutritional folate deficiency had not been produced in normal man until 1962 (Herbert 1962c) . In this study, a healthy 35-year-old physician with normal baseline erythrocyte folate stores developed folate deficiency megaloblastic anemia after four and a half months on a diet from which the folate content had been extracted by large quantities of boiling water (Herbert 1963a ). In brook trout anaemia develops after only nine weeks of folate deprivation (Phillips 1963) .
It takes approximately 120 days, or the life span of a red cell, for the normal-folate-containing red cells to be completely replaced by folatedeficient red cells, suggesting that mature erythrocytes do not release their folate until they die (Fig 1) . Other evidence (Herbert & Zalusky 1962a) indicates that folate enters only young erythrocytes and/or their precursors. Fig 2 shows the sequence of events in this instance of developing folate deficiency. This sequence parallels in many ways the sequence of events in development of deficiency of ascorbic Although various tests for intestinal malabsorption were all still normal when megaloblastosis appeared, and we described the jejunal biopsy as 'essentially normal', it did show two possibly questionable phenomena: (I) Infiltration of the lamina propria by lymphocytes. (2) Occasional large nuclei in the columnar cells. More pronounced similar phenomena were previously noted in jejunal biopsies in sprue (Butterworth & Perez-Santiago 1958) , and Ten Thije (1963) re- ported that columnar cell megaloblastic nuclei in jejunal biopsies of 2 patients with sprue and megaloblastic anemia returned to normal after folic acid therapy. Sheehy (1964) noted that American soldiers in Puerto Rico who were developing sprue had megaloblast-like nuclei in the columnar cells of their jejunal biopsies at a time when they had peripheral blood hypersegmentation and macro-ovalocytes but no anemia.
Jejunal biopsies of the experimental folate deficiency subject were taken on day 123 of folate deprivation, just before the development of anemia, and again on December 5, 1963, twentyone months after resuming a normal diet. These two biopsies show similar infiltration of lamina propria and occasional large nuclei in columnar cells, which confirms our initial impression that the jejunal biopsy was normal at a time when the bone marrow was clearly abnormal. This may suggest either that the jejunal mucosa is unaffected by pure folate deficiency or, more probably, that it keeps the tiny (-S ,ug daily) amount of ingested folate for its own needs rather than passing it on to the deprived marrow. Other possibilities are that the epithelium of the gastrointestinal tract has a selective advantage over hemopoietic cells in securing available folate, or requires less folate to sustain normality.
The 'Lobe Average' To facilitate charting of the degree of hypersegmentation, we have for several years used the 'lobe average', i.e. the total number of nuclear lobes in 100 neutrophils divided by 100 (Herbert 1962c ). This single figure is simpler to work with than the 'Arneth count' (Hynek 1909 , Arneth 1945 , Wintrobe 1939 , Herbert 1959 which is a listing of the percentage of cells with 1, 2, 3, 4 and 5 or more nuclear lobes among 100 neutrophils. In 1909 Hynek had described an almost identical simplification when he reported use of a lobe total (i.e. the number of segments in 100 neutrophils). The 'lobe average' is now being used in other laboratories in the United States, and also in London (Ardeman et al. 1963) . We feel that it will prove as useful as the MCV (mean corpuscular volume, Wintrobe 1961) in assessing megaloblastic anaemia, especially since the 'lobe average' becomes elevated before the MCV. It should be noted that not all individuals agree on what constitutes separation between lobes, and thus the 'normal' lobe average must be separately determined by each laboratory (in our laboratory, it is 3 17±0-25). The crucial factor is that the hypersegmented neutrophil seems to contain more nuclear material than normal. In our unpublished study, the area occupied by 100 nuclei was 10% greater for neutrophils from a subject with megaloblastic anemia than from a normal subject.
Incidentally, as Undritz (1952) noted, 'twinning deformities' should not be confused with 'hypersegmented neutrophils'. The former contain two nuclei in one cytoplasm, and are twice the size of normal (or hypersegmented) neutrophils. They occur rarely in normal blood and more frequently with megaloblastic anemia or blood malignancies. Fig 3 shows a 'twinning deformity' next to a four-lobed neutrophil (blood smear obtained from subject of Figs 1 and 2, seventy-eight days after onset of folate deprivation). It must be remembered that an increased lobe average occurs for unknown reasons with chronic renal disease, despite normal serum vitamin B12 and and folate levels (Herbert, unpublished) , and also with congenital hypersegmentation of the neutrophil nucleus (Undritz 1958 , Barbier 1958 . In this entity, which occurs in approximately 1 % of normal adults in Boston, the hypersegmented neurophils are oval (as in megaloblastic anaemia), but serum vitamin B12 and folate levels are normal (Herbert, Kapff & Jaskiel, unpublished) .
Therapeutic Tests in Suspected Folate Deficiency
The principles involved in the use of reticulocyte responses in therapeutic tests of erythropoietic substances were laid down in a classical paper by Minot & Castle in 1935 and have been recently reviewed (Herbert 1963b) . Although it was known that small doses of folic acid might produce therapeutic response only in patients with folate deficiency, and not in patients with vitamin B12 deficiency (Ungley 1957 , Chanarin et al. 1958 ), it was not until the study of Marshall & Jandl (1960) that a paper was devoted solely to the subject of differential diagnosis offolate deficiency from vitamin B12 deficiency by use of 'small' (0 4 mg i.m. daily) doses of folic acid. One of the 3 patients of Marshall & Jandl with vitamin B12 deficiency showed a slight reticulocyte response to this dose of folic acid, and we subsequently noted moderate reticulocyte responses in 2 patients with vitamin B12 deficiency given this dose , Herbert 1962b , 1963b . The use of 0-1 mg folic acid daily in therapeutic tests is therefore recommended , Chosy et al. 1962 , Hansen & Weinfeld 1962 . deficiency, suggesting that therapeutic tests with folic acid may be conducted as successfully orally as subsequently done with 25 ,ug folic acid daily intramuscularly (Zalusky & Herbert, unpublished) . However, when only 25 ,ug of folic acid is superimposed on an experimental diet essentially devoid of folate, there may be no therapeutic response (Sullivan & Herbert, unpublished.) of folic acid daily but not in the subjects supplemented with 50 or 100 pg daily (Herbert 1962a ). This indicated a minimal daily adult folate requirement in the range of 50 pg of folic acid, which agrees with the findings of Fleming et al. (1963) .
Other studies ) also tend to support the figure of approximately 50 pg of folic acid per day as in the range of the minimal daily folate requirement. In these studies, a 61year-old woman was sustained on the essentially no-folate diet from May 1962 until the present, and her severe folate-deficiency megaloblastic anevmia was shown to be correctable by 75 pg of folic acid daily, indicating that this quantity improved her status and that less would sustain it. Also supporting the 50 pg figure is a study in which the blood of a subject with megaloblastic anmmia returned toward normal when a diet totally devoid of folate was given, supplemented with 50 pg of folic acid daily .
Production ofOvert Megaloblastosis Within Two Weeks
The last-mentioned patient, with borderline folate deficiency and a marrow not clearly megaloblastic, developed gross overt megaloblastosis within two weeks when he was given a diet devoid of folate . This same phenomenon, rapid development of overt megaloblastosis, has been repeatedly induced within ten days by feeding alcohol to subjects with folate deficiency and borderline marrow morphology (Figs 4 and 5). In fact, there is now strong evidence that alcohol suppresses hmmopoiesis by interfering with folate metabolism as well as evidence that folate deficiency is usual in alcoholics .
Selective Concentration of L. casei Folate in Spinal Fluid
In comparing serum and spinal fluid levels of L. casei folate activity, it was found that L. casei folate selectively concentrated in spinal fluid (Herbert & Zalusky 1961b ). This raises the possibility that an antimetabolite of 5-CH3folate-H4 may be more effective therapy for malignancy affecting the nervous system than antifols such as aminopterin or methotrexate since both of these may be selectively excluded from the spinal fluid (Shaw et al. 1960 , Delmonte & Jukes 1962 . Furthermore, preliminary studies suggest that methotrexate has a half time of less than thirty minutes in the spinal fluid and may be actively transported out of the spinal fluid (W W Oppelt & D P Rall, personal communication).
We are currently studying why neurological damage more severe than sleeplessness, forgetfulness and irritability (Herbert 1962c) (Sullivan & Herbert, unpublished.) develop in folate deficiency. It may be relevant that the selective concentration of L. casei folate activity in the spinal fluid operates even during developing folate deficiency, and may (or may not) reflect an ability of the nervous system to secure folate constantly as needed. Of 11 subjects with serum L. casei folate activity between 4-2 and 6-3 ng/ml, all had normal spinal fluid L. casei folate activities (19 to 39 ng/ml), suggesting that although the serum level may have been falling, the spinal fluid level was not. Three patients with folate deficiency megaloblastic anemia had serum L. casei folate levels of 2-2, 1'9 and <1 ng/ml and spinal fluid levels of 7, 13 and 7 9 ng/ml respectively, which, while below normal, were still at least three times the serum level.
Secondary Folate Deficiency due to Vitamin B12 Deficiency The concept that much of the megaloblastic anemia of vitamin B12 deficiency may be the result of inadequate folate utilization due to the vitamin B12 deficiency has been entertained by many workers for many years (Herbert 1959 , Vilter et al. 1963 , Waters & Mollin 1963 ). Among the first 10 patients with pernicious anmmia whose serum L. casei folate activity was determined, one had an inordinately high level ). Further study showed the incidence of such high L. casei folate activity in the serum of 100 of our patients with vitamin B12 deficiency to be 17 % rather than 10 % (Herbert & Zalusky 1962a ) and demonstrated normal serum folate in many vitamin-B12-deficient subjects despite protracted reduced folate ingestion due to anorexia which should have made serum folate levels subnormal (Herbert & Zalusky 1961c) . At least two types of folate deficiency appeared to result from vitamin B12 deficiency:
(1) Inadequate folate utilization due to lack of vitamin B12. (2) Inadequate folate ingestion due to anorexia resulting from vitamin B12 deficiency. Chanarin et al. (1958) reported that Str. facalis activity disappeared rapidly from the serum of subjects with severe pernicious anemia after intravenous injection of folic acid, and interpreted this to mean 'an increase in the degree of "unsaturation" of the tissues for folic acid, and that these tissues are, therefore, depleted of the vitamin'. Reproducing their studies, but assaying not only with Str. facalis but also with L. casei, we suggested that the rapid disappearance of Str. fwcalis activity from the serum was not necessarily due to rapid removal of folate by folate-depleted tissue, but rather could be due in significant measure to rapid conversion of serum folate to a form, unavailable to Str. fwcalis but available to L. casei, which accumulated in the serum (Herbert 1961a , Herbert & Zalusky 1961a ).
These data, plus the fact that formiminoglutamate excretion in the urine of one-third of pernicious anaemia patients was inordinately high (Herbert 1959 , Herbert & Zalusky 1961d , 1962b ) delineated further the thesis (Herbert & Zalusky 1961c ) that an L. casei-active folate accumulated in the serum of vitamin-B12-deficient subjects, and that vitamin B12 is necessary for utilization of this folate (Herbert & Zalusky 1961a) .
Accumulation of L. casei-active folate in the serum in vitamin B12 deficiency has been confirmed by Waters & Mollin (1961, 1963) , Mollin et al. (1962) who used tritiated folic acid, Stevens et al. (1962) , Hansen & Weinfeld (1962) and Cooper & Lowenstein (1963) . The last two groups also found a relatively low L. casei folate activity in the erythrocytes of some patients with vitamin B12 deficiency, suggesting that vitamin B12 plays a role in the transport of folate into maturing erythrocytes. This finding is supported by our; report of an almost ten-fold greater erythrocyte L. casei folate activity of 'young' as compared to 'old' erythrocytes eight days after the start of vitamin B12 therapy for vitamin B12 deficiency.'-As we stated then (Herbert & Zalusky 1962a) : 'The phenomenon (sharp fall in serum L. casei folate on therapy with vitamin B12) may be due to release of the block in utilization of L. casei folic acid activity caused by lack of vitamin B12 with subsequent rapid utilization in hmmopoiesis, and may be similar to the fall in serum iron during therapy.' However, the proportion of the erythrocyte folate rise due to relatively greater influx and low efflux of reticulocyte folate is uncertain. It is possible that vitamin B.2 may play a role in transport of folate into all cells and/or retention of folate by cells as well as in utilization by cells. Liver L. casei and Leuconostoc citrovorum folate activities have been reported to fall to very low levels when sheep become severely vitamin-BL2deficient (Dawbarn et al. 1958) . The studies of Fischer et al. (1963) on uptake of tritium-labelled methotrexate by human leukemic leucocytes further suggest that folate uptake and retention by cells must be considered in any explanation of why a given cell has a given folate level. The nature of the folate must also be considered. For example, leucocytes take up much more folic 'It is worth noting that just before starting therapy, the patient's serum L. casei folate level was 35 ng/ml and the erythrocyte level 11 4 ng/ml; but on the seventh day of therapy she had a serum level of 5-8 ng/ml and an erythrocyte level of 252 ng/ml. On both occasions her serum Str. facalis folate level was <1 ng/ml; just before therapy her erythrocyte Str. facalis folate level was 3-8 ng/ml and on the seventh day of therapy it was 10 ng/ml. However, Cox et al. (1960) reported that whole blood Str. ficafis folate levels rose only temporarily in patients responding hamatologically to vitamin B12, folic acid, iron and acute blood loss, and subsided when the hiemoglobin rise subsided. This may suggest that the folate content of reticulocytes, however produced, is greater than that of mature erythrocytes THEA =tetrahydrofolic acid (FH4) AICAR=aminoimidazolecarboxamide ribotide (Reproducedfrom Herbert & Zalusky, 1962a, by kindpermission) acid than methotrexate. By analogy with the selective exclusion of methotrexate from the spinal fluid and the selective concentration of 5-CHg-folate-H4 therein, an antimetabolite of 5-CH3-folate-H4 might well be readily taken up by leukemic leucocytes which reject methotrexate and so provide a more effective antimetabolite therapy.
Incidentally, the fact that erythrocyte L. casei folate tends to be lowered in vitamin B1, deficiency explains why erythrocyte or whole blood L. casei folate levels show considerable overlap between patients with vitamin B1, deficiency and those with folate deficiency (Herbert, unpublished data & Mollin 1963 ) that there may be obligatory excretion of non-utilizable 5-CH3-folate-H4 in vitamin B1, deficiency requires further study. As Fig 6 would lead one to suspect, abnormally high formiminoglutamate excretion in man can be reduced by methionine , Chanarin 1963 ), glycine or vitamin B12 (Zalusky et al. 1962) . Transient rises in formiminoglutamate excretion may be produced by vitamin B12 (Herbert & Zalusky 1961c) or folic acid (Herbert 1962c ). We will not dwell here on the work of Smith et al. (1962) , Guest et al. (1962) or Weissbach et al. (1963) on the terminal reaction in the biosynthesis of methionine, involving methyl-B12, since Professor Woods discusses this (p. 388).
In conclusion, it may be mentioned that menadione, an electron acceptor which oxidizes N5-CH,-folate-H4 to N" 10-CH2-folate-H4 in vitro (Donaldson & Keresztesy 1962) does not appear to do so in vivo . What this means in terms of the block in folate utilization present in vitamin B12 deficiency awaits elucidation, but may simply mean the block is not reversible in vivo by an electron acceptor. Some of our recent thoughts on the possible biochemical mechanisms of megaloblastic anwmia are expressed in detail elsewhere (Herbert 1964) . Also presented elsewhere is a study demonstrating that accumulation of aminoimidazolecarboxamide (AIC), a purine intermediate, occurs in the urine of patients with folate deficiency (Herbert et al. 1964a ), as would be suspected from perusal of In 1951 Bakerman et al. found that rats maintained on a folic-acid-deficient diet excreted an unstable form of glutamic acid in the urine, which was subsequently identified as formiminoglutamic acid. The early work on folic acid function had shown that the amino acid histidine contributed carbon-2 of the imidazole ring to the single-carbon unit pool and it did so in the following manner (Rabinowitz 1960): The main pathway ofhistidine catabolism is to urocanic acid which is converted to formiminoglutamic acid by opening of the imidazole ring. The next stage is the transfer of the formimino-(-CH=NH) group to the folate coenzyme. If the function of the folate coenyzme is interfered with, formiminoglutamic acid (figlu) accumulates and may appear in the urine.
